StockData
CollPlant Biotechnologies Ltd logo

CollPlant Biotechnologies Ltd (CLGN) stock

CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30
$3.96+0.06 (+1.54%)

Close on Nov 11, 2026Market cap $5.72MP/E –Yield –

CollPlant Biotechnologies price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CollPlant Biotechnologies's price to sales ratio was 2.4× on Nov 11, 2026, against 54.0× a year earlier. Over the last 5 years it ranged from 1.5× to 305.3×, with a median of 7.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.4×−32.2
2025Dec 31, 202534.6×+30.8
2024Dec 31, 20243.8×−240.0
2023Dec 29, 2023243.8×+238.0
2022Dec 30, 20225.8×−21.6
2021Dec 31, 202127.3×−2.7
2020Dec 31, 202030.1×+25.1
2019Dec 31, 20195.0×−19.2
2018Dec 31, 201824.2×–

More CollPlant Biotechnologies figures

See a number that looks wrong?